Minor Ailment Remedies - UK - August 2008

Table of Contents

• Issues in the Market
• Main report themes
• Definition
• Market in Brief
• Healthy growth
• Looking after number one
• Creating interest
• Looking forward
• Internal Market Environment
• Key points
• Reduced suffering
  • Figure 1: Selected minor ailments suffered from in the last 12 months, UK, 2003-07
• Got a bad back?
• Counting sheep
• Handling hayfever
• A healthy outlook
  • Figure 2: Attitudes towards health, 2003-07
• Men offer potential, women keenest on complementary medicines
• Self-care
• Online help
• Convenience
• Own-label encroachment
• Licensing changes
  • Figure 3: Licensing changes in minor ailment remedies, 2007-08
• Broader Market Environment
• Key points
• Paying the price
  • Figure 4: Adult population trends, by socio-economic group, 2003-13
• A greying population
  • Figure 5: Structure of the UK population, by age and gender, 2003-13
• Standing alone
  • Figure 6: Trends in household size, UK, 2003-13
• Chemists get super
• Competitive Context
• Key points
• Treatments
• Complementary medicines
  • Figure 7: UK retail value sales of complementary medicines, 2003-07
• Thanks, doc
• Preventative measures
• Vitamins, minerals and supplements
  • Figure 8: Vitamin intake, 2003-07
• In context
  • Figure 9: Market value of OTC pharmaceuticals, 2003-07
• Strengths and Weaknesses in the Market
• Strengths
• Weaknesses
• Market Value and Forecast
• Key points
• Springing into action
  • Figure 11: UK retail value sales of minor ailment remedies, 2003-13
• Forecast
• Factors used in the forecast
• Segment Performance
• Key points
• Allergy remedies -- something in the air
  • Figure 12: UK retail value sales of minor ailment remedies, by type, 2005-08
• Thrush and anti-fungals -- good growth
• Topical pain/anti-rheumatic remedies -- feeling the pain
• Emollients and anti-pruritics -- return to growth
• Eyecare
• Sleeping aids -- benefiting from hectic lifestyles
• Mouth ulcers -- being run down is running up sales
• Cold sore remedies -- a soaring market
• Head-lice treatments -- star performers
• Haemorrhoid remedies -- looking for inspiration
• Best foot forward
• Scalp treatments -- a static market
• Cystitis remedies
• Travel sickness remedies -- staying steady
• Companies and Products
• Key points
• Leading manufacturers -- brand map
  • Figure 13: Brand map of the top eight minor ailment remedy manufacturers, 2008
• Own-label suppliers
  • Figure 14: Suppliers of own-label minor ailment remedies, 2008
• Leading suppliers by sector
• Hayfever and allergy remedies
  • Figure 15: Brands' retail value shares in hayfever remedies, 2003-07
• Piriton and Piriteze (GSK)
• Beconase and Flixonase (GSK)
• Benadryl (Johnson & Johnson)
• Clarityn (Schering-Plough)
• Other brands
• Emollients and anti-pruritics
  • Figure 16: Key emollient and anti-pruritic brands, 2008
• E45 (Reckitt Benckiser)
• Other brands
• Topical pain/anti-rheumatics
  • Figure 17: Key topical pain/anti-rheumatic brands, 2008
• Ibuleve (DDD)
• 4Head (DDD)
• Nurofen (Reckitt Benckiser)
• Voltarol (Novartis)
• Eyecare products
• Optrex (Reckitt Benckiser)
• Other brands
• Mouth pain/ulcer remedies
• Bonjela (Reckitt Benckiser)
• Corsodyl (GSK)
• Other brands
• Cold sores
• Zovirax (GSK)
• Compeed (Johnson & Johnson)
• Haemorrhoid remedies
• Germoloids (Bayer)
• Anusol (Johnson & Johnson)
• Head lice/infestations
• Full Marks (SSL)
• Hedrin (Thornton & Ross)
• Thrush remedies/anti-fungals
  • Figure 18: Key thrush/anti-fungal brands, 2008
• Canesten (Bayer)
• Lamisil (Novartis)
• Daktarin (Johnson & Johnson)
• Footcare
• Scholl (SSL)
• Bazuka (DDD)
• Other brands
• Sleeping aids
• Nytol (GSK)
• Scalp treatments
• Regaine (Johnson & Johnson)
• Nizoral (Johnson & Johnson)
• Travel sickness
• Kwells (Bayer)
• Stugeron 15 (Johnson & Johnson)
• Scopoderm (Novartis)
• Cystitis remedies
• Cystopurin (Bayer)
• Earcare
• Otex (DDD)
• Brand Communication and Promotion
• Key points
• Speculate to accumulate
  • Figure 19: Main monitored media advertising expenditure on selected minor ailment remedies, by major manufacturers, 2003-07
• Educate and differentiate
• Below-the-line activity
• Channels to Market
• Key points
• Multiples multiply
  • Figure 20: UK retail value sales of minor ailment remedies, by outlet type, 2006 and 2008
• Remedies to your door
• The Consumer -- Supplies and Usage
• Key points
• Stocks of minor ailment remedies
  • Figure 21: Minor ailment remedies kept in stock at home, February 2008
• What do consumers keep in stock?
• Out of stock
• They' re at that age when ...
• Family medicine cabinets are well stocked
• Unprepared
• Women are the carers
• Money tied up on the shelf
• Who uses what?
  • Figure 22: Minor ailment remedies bought or used occasionally in the past, February 2008
• Anticipate the need
• Remedy kits
• Engaging younger consumers
• Am I bothered?
• The Consumer -- Response to Symptoms
• Key points
• Response to suffering from a minor ailment
  • Figure 23: Consumer response to a minor ailment, February 2008
• Not afraid to ask
• Not so natural
• Delayed reacters provide potential
• Youthful enthusiasm
• Letting nature take its course
• Time heals?
• Pot luck with a pain-killer
• Targeting the problem
• No consultation necessary
• Professional opinion key for older patients
• Pharmacist first
• Appendix
• Advertising data
• Abbreviations
• Appendix: Internal Market Environment
  • Figure 26: Attitudes towards health, by gender, 2007
• Appendix: The Consumer -- Supplies and Usage
  • Figure 27: OTC minor ailment remedies, stock kept at home, by demographic sub-group, February 2008
  • Figure 28: OTC minor ailment remedies, stock kept at home, by demographic sub-group, February 2008
  • Figure 29: OTC minor ailment remedies, bought/used occasionally, by demographic sub-group, February 2008
  • Figure 30: OTC minor ailment remedies, bought/used occasionally, by demographic sub-group, February 2008
• Appendix: The Consumer -- Response to Symptoms
  • Figure 31: Consumer response to suffering from a minor ailment, by demographic sub-group, February 2008
  • Figure 32: Consumer response to suffering from a minor ailment, by demographic sub-group, February 2008